Head-To-Head Analysis: Babylon (NYSE:BBLN) and Privia Health Group (NASDAQ:PRVA)

Babylon (NYSE:BBLNGet Rating) and Privia Health Group (NASDAQ:PRVAGet Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings.

Risk & Volatility

Babylon has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 1.68, suggesting that its share price is 68% more volatile than the S&P 500.

Insider & Institutional Ownership

63.8% of Privia Health Group shares are held by institutional investors. 57.6% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Babylon and Privia Health Group’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Babylon $322.92 million 0.15 -$374.51 million N/A N/A
Privia Health Group $966.22 million 3.35 -$188.23 million ($2.04) -14.59

Privia Health Group has higher revenue and earnings than Babylon.


This table compares Babylon and Privia Health Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Babylon N/A N/A N/A
Privia Health Group -19.80% -47.87% -30.88%

Analyst Recommendations

This is a summary of current recommendations and price targets for Babylon and Privia Health Group, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Babylon 0 4 3 0 2.43
Privia Health Group 0 0 11 0 3.00

Babylon currently has a consensus price target of $6.00, suggesting a potential upside of 417.24%. Privia Health Group has a consensus price target of $38.09, suggesting a potential upside of 27.99%. Given Babylon’s higher probable upside, equities analysts clearly believe Babylon is more favorable than Privia Health Group.


Privia Health Group beats Babylon on 8 of the 12 factors compared between the two stocks.

About Babylon (Get Rating)

Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally. The company was founded in 2013 and is headquartered in London, the United Kingdom.

About Privia Health Group (Get Rating)

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.

Receive News & Ratings for Babylon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Babylon and related companies with MarketBeat.com's FREE daily email newsletter.